These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1126 related articles for article (PubMed ID: 2979857)

  • 21. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
    Chan PC
    Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the frequency of chromosome aberrations in the bone marrow of mice examined at various intervals after single-dose and continual exposures to cyclophosphamide.
    Srám RJ; Zhurkov VS; Nováková J; Kodýtková I
    Folia Biol (Praha); 1981; 27(1):58-65. PubMed ID: 7202767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat.
    Berger J
    Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
    Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
    Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Protective effect of Armillaria mellea polysaccharide on mice bone marrow cell damage caused by cyclophosphamide].
    Li YP; Wu KF; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2005 Feb; 30(4):283-6. PubMed ID: 15724408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of vitamin D on differentiation of hematopoietic cells, lymphocyte content, and other bone marrow cells and peripheral blood in mice].
    Palamarchuk VI; Nikolaenko NI
    Vopr Med Khim; 1993; 39(1):18-20. PubMed ID: 8388595
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
    Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
    J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of micronuclei in mouse bone marrow after combined X-rays-cyclophosphamide and X-rays-mitomycin C treatments.
    Dobrzyńska MM; Gajewski AK
    Teratog Carcinog Mutagen; 1999; 19(4):267-74. PubMed ID: 10406890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked granulocytosis in C57BL/6 mice bearing a transplanted BMT-11 fibrosarcoma.
    Ishikawa M; Hosokawa M; Oh-hara N; Niho Y; Kobayashi H
    J Natl Cancer Inst; 1987 Mar; 78(3):567-71. PubMed ID: 3469467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of c-myb transcription in autoimmune disease by cyclophosphamide.
    Mountz JD; Mushinski JF; Smith HR; Klinman DM; Steinberg AD
    J Immunol; 1985 Oct; 135(4):2417-22. PubMed ID: 4031495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of taurine on leucocyte function.
    Wang L; Zhao N; Zhang F; Yue W; Liang M
    Eur J Pharmacol; 2009 Aug; 616(1-3):275-80. PubMed ID: 19490912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of pretreatment with cyclophosphamide on high-dose toxicity of melphalan in mice.
    Kulkarni SS; Leventon GS; Huynh L; Chow H; Dicke KA; Zander AR
    Cancer Res; 1985 Nov; 45(11 Pt 1):5431-5. PubMed ID: 3902211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of immunotoxicity induced by diazinon in C57bl/6 mice.
    Neishabouri EZ; Hassan ZM; Azizi E; Ostad SN
    Toxicology; 2004 Mar; 196(3):173-9. PubMed ID: 15036744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow morphology during haematopoietic stem cell mobilisation with cyclophosphamide in mice.
    Karbicka A; Marchlewicz M; Wiszniewska B; Machaliński B
    Folia Morphol (Warsz); 2003 Nov; 62(4):435-7. PubMed ID: 14655135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclophosphamide pretreatment induces eosinophilia to nonparasite antigens.
    Vadas MA
    J Immunol; 1981 Nov; 127(5):2083-6. PubMed ID: 7299123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A granulocytosis-inducing tumor inhibits the production of B lymphocytes in murine bone marrow.
    Fülöp G; Lee MY; Rosse C
    J Immunol; 1985 Dec; 135(6):4266-72. PubMed ID: 3877765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice.
    Maestroni GJ; Covacci V; Conti A
    Cancer Res; 1994 May; 54(9):2429-32. PubMed ID: 8162592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.